CDH17 and Alzheimer disease: Therefore, cadherin peptides or BBBMs can be used as an adjuvant to enhance the delivery of therapeutic or diagnostic agents into the brain for brain diseases such as Alzheimer’s disease (AD), brain tumor, and multiple sclerosis (MS).